Apogee Therapeutics, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-06-30 was 240.85K shares, a 1040.23% increase year-over-year.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2026-03-31 was 139.81K shares, a 385.48% increase year-over-year.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 156.43K shares, a 611.54% increase year-over-year.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 15.75K shares, a 18.67% decline year-over-year.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 222.10K shares, a 416.22% increase from fiscal 2024.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 43.02K shares.
- Apogee Therapeutics, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2026-06-30 | 240.85K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | 552.85K shares derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | 139.81K shares 10-Q · filed 2026-05-11 | 333.12K shares derived: sum of 4 quarters · filed 2026-05-11 |
| 2025-12-31 | 156.43K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | 222.10K shares 10-K · filed 2026-03-02 |
| 2025-09-30 | 15.75K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 87.66K shares derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | 21.12K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | 91.27K shares derived: sum of 4 quarters · filed 2025-08-11 |
| 2025-03-31 | 28.80K shares 10-Q · filed 2025-05-12 | 70.78K shares derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | 21.98K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 43.02K shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 19.36K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | |
| 2024-06-30 | 628.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | |
| 2024-03-31 | 1.05K shares 10-Q · filed 2024-05-13 | |
| 2023-12-31 | 0.00 shares 10-K · filed 2026-03-02 |